Visiongain Assesses that the Contract Research Organisations (CROs) Market will Generate Revenues of $38.0 Billion

Visiongain Assesses that the Contract Research Organisations (CROs) Market will Generate Revenues of $38.0 Billion

PR Newswire

LONDON, March 16, 2020

- Global Contract Research Organisations (CROs) Market Report Forecasts 2020-2030

- Forecasts & Analysis by Service, by Application, by End-User Including Forecasts by Major Regions and Countries, Plus Profiles of Leading Companies in the Market

LONDON, March 16, 2020 /PRNewswire/ -- The new report from business intelligence provider Visiongain offers an updated outlook for the global clinical research organizations (CROs) market. Visiongain assesses that the clinical research organizations (CROs) market will generate revenues of $38.0 billion in 2020. Contract research organizations (CROs) have become essential to pharmaceutical, biotech and other medical-related industries by supporting their clients' efforts to test, refine and market the latest pharmaceuticals and medical devices through clinical trials.

Visiongain Logo

The global CRO market value has grown by nearly a 9.5% compound annual growth rate (CAGR) over the past several years and is expected to reach $38 billion in 2020 and $94 billion by 2030, as specialized demand, patent expiration and proliferation of generic medications are all leading to greater outsourcing of work to CROs. Also driving the trend toward CRO outsourcing is pharmaceutical companies' (pharma companies') increasing need to reduce clinical trial costs and improve efficiencies. This in turn is increasing time-to-market urgencies for pharma companies while also leading to pricing pressures and greater margin awareness. Pharmaceutical companies are focusing on niche sector CROs to expand their knowledgebase in highly complex trial areas, and functional service provider (FSP) contracts are allowing them the ability to outsource individual services rather than entire studies or projects. This integrated Pharma-CRO partnership leads to efficiency gains and is often desirable for studies of high complexity, tight time constraints and/or broader scope.

Strong demand and increased competitiveness are facilitating mergers and partnerships to enhance larger companies' full-service capabilities and international reach. Recovery of capital markets and strong revenue potential are boosting CRO valuations, which is also increasing merger and acquisition (M&A) activity and public offerings in the industry.

Pharma pipelines are currently ripe with new-age, complex therapies that are nearing market readiness. Regenerative cell-based therapies, chimeric antigen receptor (CAR)-modified T cell therapy (CAR-T), immune-oncology combinations and innovative autoimmune therapies are just some of the new fields being studied in clinical trials across the globe. More adept use of data and analytics by pharma and CROs is leading to more appropriate patient trial selection and more adaptive trial designs. Adaptive design studies, risk-based monitoring and other flexible approaches can reduce costs while allowing adaptions as studies progress. These trends mitigate risks for pharma companies and patient pools while facilitating the pursuit of more potential therapies and enhancing the drug discovery pipeline. Correspondingly, patient receptiveness is at an all-time high. These factors are all contributing to the rapid proliferation of clinical trials in the U.S. and throughout the globe.

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-contract-research-organisations-cros-market-report-forecasts-2020-2030/#download_sampe_div

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in the clinical research organizations (CROs) sector. Visiongain's new study tells you and tells you NOW.

In this brand-new report, you will receive 214 in-depth tables, charts and graphs– all unavailable elsewhere.

The 215-page report provides clear detailed insight into the global clinical research organizations (CROs) market. It reveals the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you will be better informed and ready to act.

Report Scope

• Global clinical research organizations (CROs) market forecasts from 2020-2030

• Regional clinical research organizations (CROs) market forecasts from 2020-2030 covering
North America
South America
Western Europe
Eastern Europe
Asia-Pacific
Middle East and Africa

• Country level clinical research organizations (CROs) forecasts from 2020-2030 covering
– US
Canada
Mexico
– UK
Germany
Japan
Brazil
India
– RoW

• Clinical Research Organizations (CROs) submarket forecasts from 2020-2030 covering services
– Drug Discovery
– Pre-Clinical & Clinical
– Laboratory Services
– Other Service

• Clinical Research Organizations (CROs) submarket forecasts from 2020-2030 covering Application
– Cardiology
– Infectious Disease
– Oncology
– Metabolic Disorders
– Other Applications

• Clinical Research Organizations (CROs) submarket forecasts from 2020-2030 covering End-Users
– Pharmaceutical & Biotechnological Companies
– Academic & Research Institutes

• Analysis of the key factors driving growth in the global, regional and country level clinical research organizations (CROs) markets from 2020-2030

Profiles and competitive positioning map of the leading 10 clinical research organizations (CROs) companies
• Charles River Laboratories
• Frontage Laboratories, Inc.,
• Icon Plc
• Syneos Health, Inc. (Inc Research/Inventive Health)
• LabCorp/Covance
• Parexel
• Pharmaceutical Product Development
• PRA Health Services
• Quintiles
• WuXiAppTec

How will you benefit from this report?
• This report will keep your clinical research organizations (CROs) knowledge base up to speed. Don't get left behind
• This report will reinforce strategic decision decision-making based upon definitive and reliable market data
• You will learn how to exploit new clinical research organizations (CROs) technological trends
• You will be able to realise your company's full potential within the market
• You will better understand the competitive landscape and identify potential new business opportunities & partnerships

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-contract-research-organisations-cros-market-report-forecasts-2020-2030/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Companies Profiles
Charles River Laboratories
Frontage Laboratories, Inc.,
Icon Plc
Syneos Health, Inc. (Inc Research/Inventive Health)
LabCorp/Covance
Parexel
Pharmaceutical Product Development
PRA Health Services
Quintiles
WuXiAppTec

Other Companies
4Clinics
Aagami
Absorption Systems
Accelsiors
ACI Clinical
Actimus Bio
Advanced BioScience Laboratories
Advanced Clinical Research Institute
Agilent
Albuquerque Clinical Trials (ACT)
AlcheraBio
Allphase Clinical Research
Amarex Clinical Research
APCER Life Sciences
Applied Healthcare Resource Management (AHRM)
ArisGloba
At Clinical Systems
Avail Clinical Research
Axio Research
AXON
Universal Research Group
BBK
Bio Reliance Corporation
BioFortis
BioRASI Clinical Research
Biotrial
Boston MedTech Advisors
Bradstreet Clinical Research
Burleson Research Technologies (BRT)
Cambridge Biomedical
CATO Research
Celerion
Clinical Research Management Group
Clinical Supplies Management Holdings
Clinipace
A10 Clinical Solutions
ABF Pharmaceutical Services
Accell Clinical Research
Accumedix, Inc
ACM Global Laboratories
Acurian
Advanced Clinical Research (ACR)
Advanced Clinical Services LLC
Akos Urgent Care
Alcami
Alliance for Clinical Trials in Oncology
AlphaGenesis Incorporated (AGI)
Anabase
Applied Biosystems
Aptuit
ARS Clinical Trials
Aurum Clinical Research
Avitacor
AXIS Clinicals
Axon Medchem
BASi
Bio Analytical Research Corporation (BARC)
BioClinica
BioPharma Services Inc
Biostat International
Blue Sky BioServices
Bracket
Bright Pharmaceutical Services
Camargo Pharmaceutical Services
Catalent
CCS Associates
Clinical Research Consulting, Inc.
Clinical Site Services (CSS)
Clinilabs
CliniRx
Advanced Clinical Services LLC
Aptuit
Astron Research
BioClinica
Bracket
Chembiotech Laboratories
Clinlogix
Cmed
CrownBio
Ergomed
hVIVO
OPIS
Pharm-Olam
Pharmalys
Premier Research
Progressive Life Sciences
RenaSci
RTI Health Solutions
Simbec Research
Solicitors Regulation Authority
Synteract
The Clinical Trial Company
Theradex
Venn Life Sciences
ZEINCRO
Applied Healthcare Resource Management (AHRM)
ArisGloba
AXON
Biotrial
Celerion
Clinical Site Services (CSS)
ClinTec International
Congenix
Cyprotex Limited
ERT
MAPI
Orphan Reach
Pharmaceutical Development Services
PharSafer
PrimeVigilance
Quanticate
Richmond Pharmacology
Selcia
Smithers Viscient
Source BioScience Limited
TAKE Solutions
The Smerud Medical Research Group
Transcom Global
Veristat

To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com 

Related reports:

Clinical Laboratory Tests Market Report 2019-2029

Clinical Trial Imaging Market Report 2019-2029

Clinical Oncology Next Generation Sequencing (NGS) Market Report 2019-2029

Clinical Decision Support Systems (CDSS) Market Report 2019-2029

Clinical Laboratory Services Market Report 2019-2029

Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

Voltar noticias em Inglês